Overlapping NMDA-R and GFAP Antibody Autoimmune Encephalitis After Nivolumab Therapy

The differential diagnosis associated with acute encephalopathy is broad; however, given the increasing frequency with which immunotherapy is being used in the treatment of cancer, consider checkpoint inhibitor-induced autoimmune encephalitis in the appropriate clinical context.

Source: Neurology Clinical Practice - December 13, 2021 Category: Neurology Authors: Ayala, F. A., Dougherty, S. C., Swift, W., Lapides, D. A. Tags: Autoimmune diseases, Encephalitis, Endocrine, Critical care Case Source Type: research